Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Karoly Nikolich Insider Profile
4 Followers
Karoly Nikolich, Director at Pascal Biosciences Inc, holds 316.67K shares in Pascal Biosciences Inc (Ticker: TSE:NEVI).
Karoly Nikolich has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Karoly Nikolich's holdings
Insider Roles
Director
Roles that Karoly Nikolich holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 23, 2015 - Nov 23, 2016
Return:+18.40%
The most profitable trade made by Karoly Nikolich
Karoly Nikolich's Trading History
List of latest transactions for each holding click on a transaction to see Karoly Nikolich's performance on stock
You May Also Like
Karoly Nikolich insider profile FAQ
What is the percentage of profitable transactions made by Karoly Nikolich?
The percentage of profitable transactions made by Karoly Nikolich is ―.
What is the average return per transaction made by Karoly Nikolich?
The average return per transaction made by Karoly Nikolich is ―.
What stocks does Karoly Nikolich hold?
Karoly Nikolich holds: TSE:NEVI stocks.
What was Karoly Nikolich’s latest transaction?
Karoly Nikolich latest transaction was an Uninformative Sell of C$30.00K.
What was Karoly Nikolich's most profitable transaction?
Karoly Nikolich’s most profitable transaction was an Informative Buy of TSE:NEVI stock on November 23, 2015. The return on the trade was 18.40%.
What is Karoly Nikolich's role in Pascal Biosciences Inc?
Karoly Nikolich's role in Pascal Biosciences Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.